However, there are two questions: (1) whether the imbalances between IL-6 and TGF-β and between Th17 and Treg occur in depression; and (2) whether low-dose IL-2 can improve depression by restoring these imbalances. This evidence concerns the gene IL2 and depressive symptom measurement.